Metabonomics combined with molecular biology were used to investigate the mechanisms of anti-dilated cardiomyopathy treated by depside salt from Salvia miltiorrhiza. The serum metabolic profiling of control group, model group and treatment group were analysed by principle component analysis(PCA). The potential biomarkers were selected with the help of orthogonal partial least squares discriminant analysis(OPLS-DA). As results, nine potential biomarkers including the PS[16∶0/18∶1(9Z)], LysoPC(16∶0), LysoPC[20∶4(5Z, 8Z, 11Z, 14Z)], LysoPC[22∶6(4Z, 7Z, 10Z, 13Z, 16Z, 19Z)], cholesterol sulfate, taurohyocholate, γ-linolenic acid, docosapentaenoic acid and 9'-carboxy-γ-chromanol were identified respectively. In addition, the relative content of γ-linolenic acid, docosapentaenoic acid and 9'-carboxy-γ-chromanol decreased in the model group, while increased in the treatment group. With the help of western bloting and enzyme-linked immunosorbent method, we confirmed that the depside salt from Salvia miltiorrhiza influenced the expression levels of superoxide disproportionation(SOD), malondialdehyde(MDA), Bcl-2 and Bax protein molecule(the proteins mentioned above were related with γ-linolenic acid and 9'-carboxyl-γ-tocopherol), and then reduced the amount of the apoptosis myocardial cell induced by oxidative stress, and treated the the dilated cardiomyopathy caused by adriamycin finally.